Why Some Employers Are Scaling Back GLP-1 Coverage
After initially expanding weight-management drug benefits, some employers have added stricter requirements or dropped coverage entirely, citing cost.
By the GLP Semaglutide editorial team · Last updated May 25, 2026
Several large employers publicly expanded GLP-1 weight-management coverage as demand grew, then later added stricter prior-authorization requirements, BMI thresholds, or program participation requirements (like enrollment in a lifestyle coaching program) as the cost of covering a broad population became clearer.
The underlying cost math
GLP-1 drugs carry a high list price and are intended for long-term, often indefinite use for weight management, which creates a materially different cost profile for a self-insured employer than a short-course medication — a dynamic benefits consultants have flagged repeatedly in employer surveys.
What this means for employees
Coverage terms can change at open enrollment or mid-year for self-insured plans in some circumstances. Checking current plan documents directly, rather than assuming last year's coverage still applies, is the only reliable way to know your specific benefit.
Primary sources